Iron Horse Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$12.5K Hold
143
﹤0.01% 252
2025
Q1
$12.8K Sell
143
-1
-0.7% -$89 ﹤0.01% 240
2024
Q4
$11.5K Hold
144
﹤0.01% 225
2024
Q3
$13K Hold
144
﹤0.01% 216
2024
Q2
$11.3K Hold
144
﹤0.01% 208
2024
Q1
$12.6K Sell
144
-480
-77% -$41K 0.01% 179
2023
Q4
$51.4K Hold
624
0.02% 79
2023
Q3
$48.9K Buy
624
+23
+4% +$1.93K 0.02% 81
2023
Q2
$52.9K Hold
601
0.03% 74
2023
Q1
$48.5K Buy
601
+300
+100% +$24.5K 0.02% 77
2022
Q4
$23K Buy
301
+50
+20% +$4.05K 0.01% 95
2022
Q3
$20K Buy
251
+250
+25,000% +$22.5K 0.03% 64
2022
Q2
$0 Hold
1
﹤0.01% 292
2022
Q1
$0 Hold
1
﹤0.01% 250
2021
Q4
$0 Hold
1
﹤0.01% 236
2021
Q3
$0 Buy
+1
New +$129 ﹤0.01% 225

Other funds holding MDT

Iron Horse Wealth Management's MDT Position: Q2 2025 in Review

Iron Horse Wealth Management held its Medtronic (MDT) position steady in Q2 2025 at 143 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Iron Horse Wealth Management first reported a position in MDT in Q3 2021 and has held it in 16 quarters since. The position peaked at $52.9K in Q2 2023. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Iron Horse Wealth Management held 143 shares of Medtronic worth $12.5K as of Q2 2025.
  • Iron Horse Wealth Management left its Medtronic share count unchanged in Q2 2025.
  • Medtronic made up ﹤0.01% of Iron Horse Wealth Management's portfolio in Q2 2025, its #252 holding.
  • Iron Horse Wealth Management first reported a position in Medtronic in Q3 2021 and has held it in 16 quarters since.
  • Iron Horse Wealth Management's Medtronic position peaked at $52.9K in Q2 2023.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.